Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/BAYER-AG-436063/news/Bayer-US-Gesundheitsbehorde-FDA-genehmigt-die-zusatzliche-Anwendung-von-Darolutamid-in-Kombinati-41236397/?utm_source=whatsapp&utm_medium=social&utm_campaign=share